Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

Completed

Phase N/A Results N/A

Summary of Purpose

The Alpha-Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study was a large randomized, double-blind, placebo-controlled, 2x2 factorial design, primary prevention trial testing the effects of alpha-tocopherol and beta-carotene supplements on cancer incidence and mortality conducted in Finland as a collaboration between the Public Health Institute (KTL) of Finland and the U.S. National Cancer Institute. The...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 October 2017.

31 Aug 1985 19 Jun 2006 Unavailable Unavailable 19 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Perspective: Prospective

Contacts

Not available